2023
DOI: 10.1039/d3bm00325f
|View full text |Cite
|
Sign up to set email alerts
|

A biocompatible nano-barium sulfonate system for quad-modal imaging-guided photothermal radiotherapy of tumors

Abstract: Integration of multi-modal imaging techniques and various cancer treatments based on their respective characteristics would be beneficial to enhance anticancer efficacy. Exploiting an “all-in-one” nanoparticle with high biocompatibility has attracted...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 42 publications
0
1
0
Order By: Relevance
“…ICG could generate fluorescence, hyperthermia and singlet oxygen upon 808 nm laser irradiation, which allows ICG to be used for molecular imaging and phototherapy in cancer diagnosis and therapeutics (Chen et al., 2016; Hong et al., 2022; Pollmann et al., 2023). Besides, ICG has been widely investigated to combine with other therapeutics such as immunotherapy, chemotherapy and radiotherapy to better suppress cancer (Lian et al., 2023; Lu et al., 2023; Sun et al., 2022; Tu et al., 2020). However, ICG exhibits poor stability in aqueous solution and short plasma half‐life time in vivo, which significantly limit its applications for both cancer diagnosis and therapeutics (Hu, Chen, et al., 2019; Hu et al., 2017; Saxena et al., 2003).…”
Section: Introductionmentioning
confidence: 99%
“…ICG could generate fluorescence, hyperthermia and singlet oxygen upon 808 nm laser irradiation, which allows ICG to be used for molecular imaging and phototherapy in cancer diagnosis and therapeutics (Chen et al., 2016; Hong et al., 2022; Pollmann et al., 2023). Besides, ICG has been widely investigated to combine with other therapeutics such as immunotherapy, chemotherapy and radiotherapy to better suppress cancer (Lian et al., 2023; Lu et al., 2023; Sun et al., 2022; Tu et al., 2020). However, ICG exhibits poor stability in aqueous solution and short plasma half‐life time in vivo, which significantly limit its applications for both cancer diagnosis and therapeutics (Hu, Chen, et al., 2019; Hu et al., 2017; Saxena et al., 2003).…”
Section: Introductionmentioning
confidence: 99%